Impact of the BETACONNECT Auto-injector on BETASERON Therapy Adherence and Patient Satisfaction
Public ClinicalTrials.gov record NCT02652091. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to assess adherence and persistence to BETASERON therapy in patients who are using the BETACONNECT auto-injector device (BETACONNECT device). The secondary objective of this study is to assess patient-reported satisfaction with the BETACONNECT device.
Study identification
- NCT ID
- NCT02652091
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 146 participants
Conditions and interventions
Conditions
Interventions
Drug · Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 4, 2016
- Primary completion
- Aug 10, 2017
- Completion
- Sep 12, 2017
- Last update posted
- Sep 5, 2018
2016 – 2017
United States locations
- U.S. sites
- 23
- U.S. states
- 14
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Cullman | Alabama | 35058 | — |
| Not listed | Boca Raton | Florida | 33428 | — |
| Not listed | New Port Richey | Florida | 34653 | — |
| Not listed | Tampa | Florida | 33609 | — |
| Not listed | Atlanta | Georgia | 30309-1465 | — |
| Not listed | Fulton | Maryland | 20759 | — |
| Not listed | Foxborough | Massachusetts | 02035 | — |
| Not listed | Deckerville | Michigan | 48427 | — |
| Not listed | St Louis | Missouri | 63131 | — |
| Not listed | Stratford | New Jersey | 08084 | — |
| Not listed | Teaneck | New Jersey | 07666 | — |
| Not listed | Staten Island | New York | 10306 | — |
| Not listed | Medford | Oregon | 97504 | — |
| Not listed | Medford | Oregon | — | — |
| Not listed | Bala-Cynwyd | Pennsylvania | 19004 | — |
| Not listed | Lititz | Pennsylvania | 17543 | — |
| Not listed | Franklin | Tennessee | 37064 | — |
| Not listed | Memphis | Tennessee | 38104 | — |
| Not listed | Nashville | Tennessee | 37212 | — |
| Not listed | Lubbock | Texas | 79430 | — |
| Not listed | Round Rock | Texas | 78681 | — |
| Not listed | Fairfax | Virginia | 22031 | — |
| Not listed | Virginia Beach | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02652091, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 5, 2018 · Synced Sep 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02652091 live on ClinicalTrials.gov.